| Interleukin-2 and regulatory T cells in graft-versus-host disease J Koreth, K Matsuoka, HT Kim, SM McDonough, B Bindra, EP Alyea III, ... New England Journal of Medicine 365 (22), 2055-2066, 2011 | 1258 | 2011 |
| KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... The Lancet 398 (10299), 491-502, 2021 | 524 | 2021 |
| PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine J Rosenblatt, B Glotzbecker, H Mills, B Vasir, D Tzachanis, JD Levine, ... Journal of immunotherapy 34 (5), 409-418, 2011 | 350 | 2011 |
| Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells D Tzachanis, GJ Freeman, N Hirano, AAFL Van Puijenbroek, MW Delfs, ... Nature immunology 2 (12), 1174-1182, 2001 | 312 | 2001 |
| Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients J Rosenblatt, I Avivi, B Vasir, L Uhl, NC Munshi, T Katz, BR Dey, ... Clinical cancer research 19 (13), 3640-3648, 2013 | 235 | 2013 |
| Lenalidomide enhances anti-myeloma cellular immunity K Luptakova, J Rosenblatt, B Glotzbecker, H Mills, D Stroopinsky, T Kufe, ... Cancer immunology, immunotherapy 62, 39-49, 2013 | 179 | 2013 |
| Antipsychotic drugs: from receptor-binding profiles to metabolic side effects S Siafis, D Tzachanis, M Samara, G Papazisis Current neuropharmacology 16 (8), 1210-1223, 2018 | 170 | 2018 |
| Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma OO Oluwole, K Bouabdallah, J Muñoz, S De Guibert, JM Vose, NL Bartlett, ... British journal of haematology 194 (4), 690-700, 2021 | 133 | 2021 |
| CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma JR Berenson, A Cartmell, A Bessudo, RM Lyons, W Harb, D Tzachanis, ... Blood, The Journal of the American Society of Hematology 127 (26), 3360-3368, 2016 | 117 | 2016 |
| Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics LJ Appleman, D Tzachanis, T Grader-Beck, AAFL Van Puijenbroek, ... Journal of molecular medicine 78, 673-683, 2001 | 77 | 2001 |
| Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses D Tzachanis, A Berezovskaya, LM Nadler, VA Boussiotis Blood, The Journal of the American Society of Hematology 99 (4), 1465-1473, 2002 | 74 | 2002 |
| Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+ CD103+ regulatory T cells in vivo L Li, RJ Greenwald, EM Lafuente, D Tzachanis, A Berezovskaya, ... The Journal of Immunology 175 (5), 3133-3139, 2005 | 71 | 2005 |
| Pregabalin's abuse potential: a mini review focusing on the pharmacological profile. G Papazisis, D Tzachanis International journal of clinical pharmacology and therapeutics 52 (8), 709-716, 2014 | 61 | 2014 |
| Immunomodulatory effects of vitamin D: implications for GVHD J Rosenblatt, A Bissonnette, R Ahmad, Z Wu, B Vasir, K Stevenson, ... Bone marrow transplantation 45 (9), 1463-1468, 2010 | 61 | 2010 |
| Hematopoietic cell transplantation, version 2.2020, NCCN clinical practice guidelines in oncology A Saad, M de Lima, S Anand, VR Bhatt, R Bookout, G Chen, D Couriel, ... Journal of the National Comprehensive Cancer Network 18 (5), 599-634, 2020 | 58 | 2020 |
| Intrinsic and extrinsic regulation of T lymphocyte quiescence D Tzachanis, EM Lafuente, L Li, VA Boussiotis Leukemia & lymphoma 45 (10), 1959-1967, 2004 | 51 | 2004 |
| Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression D Tzachanis, VA Boussiotis Cell cycle 8 (7), 1019-1025, 2009 | 49 | 2009 |
| Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external … BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... Journal of hematology & oncology 15 (1), 170, 2022 | 43 | 2022 |
| Neuroprotection by lamotrigine in a rat model of neonatal hypoxic-ischaemic encephalopathy G Papazisis, K Kallaras, A Kaiki-Astara, C Pourzitaki, D Tzachanis, ... International Journal of Neuropsychopharmacology 11 (3), 321-329, 2008 | 42 | 2008 |
| Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic D Mauri, K Kamposioras, M Tolia, F Alongi, D Tzachanis, B Petricevic, ... The Lancet Oncology 21 (6), 759-760, 2020 | 37 | 2020 |
